Cargando…

Parkinson’s Disease and Melanoma: Co-Occurrence and Mechanisms

Parkinson’s disease (PD) is a neurodegenerative disorder that is characterized by loss of dopaminergic neurons in the substantia nigra pars compacta, depletion of dopamine in the striatum and the presence of Lewy bodies. Cancer is uncontrolled growth of cells in the body and migration of these cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bose, Anindita, Petsko, Gregory A., Eliezer, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130416/ https://www.ncbi.nlm.nih.gov/pubmed/29991141 http://dx.doi.org/10.3233/JPD-171263

Ejemplares similares

Co-occurrence of multiple sclerosis and Parkinson disease
por: Shaygannejad, Vahid, et al.
Publicado: (2016)

Early occurrence of inspiratory muscle weakness in Parkinson’s disease
por: Baille, Guillaume, et al.
Publicado: (2018)

Melanoma and CLL co-occurrence and survival: role of KC history
por: Zhao, Yayi, et al.
Publicado: (2023)

Brait-Fahn-Schwartz Disease: A Unique Co-Occurrence of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
por: Aslam, Ayesha, et al.
Publicado: (2023)

Feet in mouth disease
por: Petsko, Gregory A
Publicado: (2005)

The association between Parkinson’s disease and melanoma: a systematic review and meta-analysis
por: Huang, Pei, et al.
Publicado: (2015)

Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease
por: Chen, Cang, et al.
Publicado: (2019)

Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson's Disease
por: Wei, Jianshe, et al.
Publicado: (2021)

Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Calciphylaxis and its co‐occurrence with connective tissue diseases
por: Zhou, Yueyuan, et al.
Publicado: (2022)

The Correlation between Osteoporosis Occurrences in Both Schizophrenia and Parkinson’s Disease
por: Radaei, Fatemeh, et al.
Publicado: (2014)

Association of Depression With Early Occurrence of Postural Instability in Parkinson’s Disease
por: Hwang, Yun Su, et al.
Publicado: (2023)

Clinicopathologic Characteristics of Melanoma in Patients with Parkinson Disease
por: Flynn, M. Seth, et al.
Publicado: (2022)

Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
por: Pajares, Marta, et al.
Publicado: (2020)

GBA Variants and Parkinson Disease: Mechanisms and Treatments
por: Smith, Laura, et al.
Publicado: (2022)

Protective Mechanisms of Flavonoids in Parkinson's Disease
por: Magalingam, Kasthuri Bai, et al.
Publicado: (2015)

Endobronchial Malignant Melanoma: An Exceedingly Rare Occurrence
por: Ghani, Marium, et al.
Publicado: (2020)

Parkinson’s disease following COVID-19: causal link or chance occurrence?
por: Li, Wei-Shan, et al.
Publicado: (2020)

The Influence of Serum Uric Acid Level on Non-Motor Symptoms Occurrence and Severity in Patients with Idiopathic Parkinson’s Disease and Atypical Parkinsonisms—A Systematic Review
por: Grażyńska, Anna, et al.
Publicado: (2021)

Biological mechanisms of aging predict age‐related disease co‐occurrence in patients
por: Fraser, Helen C., et al.
Publicado: (2022)

Melanoma Cell Death Mechanisms
por: Broussard, Lindsey, et al.
Publicado: (2018)

Parkinson’s disease and diabetes mellitus: common mechanisms and treatment repurposing
por: Labandeira, Carmen M., et al.
Publicado: (2022)

Defining an amyloid link Between Parkinson’s disease and melanoma
por: Dean, Dexter N., et al.
Publicado: (2020)

Headache and Tremor: Co-occurrences and Possible Associations
por: Kuiper, Mathys, et al.
Publicado: (2015)

Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
por: Tsigelny, Igor F., et al.
Publicado: (2008)

Co-occurrence of Malignant Melanoma and Squamous Cell Carcinoma on Burn Scars: A Case Report
por: Sasaki, Naoki, et al.
Publicado: (2023)

Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease
por: Xie, Anmu, et al.
Publicado: (2014)

Basic mechanisms of rTMS: Implications in Parkinson's disease
por: Arias-Carrión, Oscar
Publicado: (2008)

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson’s disease
por: Vadalà, Maria, et al.
Publicado: (2015)

c-Abl and Parkinson’s Disease: Mechanisms and Therapeutic Potential
por: Brahmachari, Saurav, et al.
Publicado: (2017)

Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson’s Disease
por: Powers, Robert, et al.
Publicado: (2017)

Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
por: Surguchov, Andrei
Publicado: (2021)

New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
por: Tan, Jolene Su Yi, et al.
Publicado: (2020)

Cognition Deficits in Parkinson's Disease: Mechanisms and Treatment
por: Fang, Congcong, et al.
Publicado: (2020)

Mechanisms of peripheral levodopa resistance in Parkinson’s disease
por: Beckers, Milan, et al.
Publicado: (2022)

Melanoma Brain Metastasis: Mechanisms, Models, and Medicine
por: Kircher, David A., et al.
Publicado: (2016)

APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis
por: Crews, Leslie, et al.
Publicado: (2009)

Progressive Resistance Exercise and Parkinson's Disease: A Review of Potential Mechanisms
por: David, Fabian J., et al.
Publicado: (2012)

The Occurrence of Fatigue in Independent and Clinically Stable Filipino Patients with Idiopathic Parkinson’s Disease
por: Rabo, Carter S., et al.
Publicado: (2009)

Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease
por: Palacios, Natalia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nhevmfdovg3s2s4njgtjbffifk